[Clinical remission of classic Kaposi sarcoma with topical 5% imiquimod].
Echeverría-García
B
B
Sanmartín
O
O
Guillén
C
C
D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000627:therapeutic use*; D000279:Administration, Cutaneous; D000368:Aged; D000634:Aminoquinolines / Q000008:administration & dosage / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D003475:Curettage; D004564:Electrocoagulation; D005534:Foot Diseases / Q000188:drug therapy* / Q000532:radiotherapy / Q000601:surgery; D006801:Humans; D000077271:Imiquimod; D008297:Male; D010412:Penile Neoplasms / Q000532:radiotherapy / Q000601:surgery; D012074:Remission Induction; D012514:Sarcoma, Kaposi / Q000188:drug therapy* / Q000532:radiotherapy / Q000601:surgery; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy / Q000601:surgery
D000276:Adjuvants, Immunologic; D000634:Aminoquinolines; D000970:Antineoplastic Agents; D000077271:Imiquimod